Funder
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference16 articles.
1. Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(4):109–117.
2. Kobayashi M. Considerations for age-based and risk-based use of PCV15 and PCV20 among U.S. adults and proposed policy options. ACIP meeting Pneumococcal Vaccines 2021; https://stacks.cdc.gov/view/cdc/110908. Accessed 10 Feb 2022.
3. Stoecker C. Economic assessment of PCV15 & PCV20. ACIP meeting Pneumococcal Vaccines 2021; https://stacks.cdc.gov/view/cdc/109109. Accessed 10 Feb 2022.
4. Leidner AJ. Summary of three economic models assessing pneumococcal vaccines in US adults. ACIP meeting Pneumococcal Vaccines 2021; https://stacks.cdc.gov/view/cdc/110717. Accessed 10 Feb 2022.
5. Nowalk MP, Wateska AR, Lin CJ, et al. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the U.S. J Natl Med Assoc. 2019;111(5):540–5.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献